Sign in
4

Changes in Ownership

Arcutis Biotherapeutics, Inc. Filed Acc 0001628280-26-014328

Edwards Larry Todd sold 3,687 shares at an average $25.18 ($92,846)

  • Edwards Larry Todd acquired 30,000 shares (grant or award)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Edwards Larry Todd

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-27 Grant or award : show line 1 in the form 10b5-1 +30,000 178,865 D
2026-03-02 Sale : show line 2 in the form 10b5-1 −3,584 $25.16 $90,177 175,281 D
2026-03-02 Sale : show line 3 in the form 10b5-1 −103 $25.91 $2,669 175,178 D
Open-market sales · 3,687 sh · avg $25.18 · $92,846

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-27 Grant or award : show line 4 in the form 10b5-1 Stock Option (right to buy) +77,000 77,000 D
Loading xslF345X05/wk-form4_1772588580.xml…